Inhibition of trigeminal neurons by intravenous administration of the serotonin (5HT)1B/D receptor agonist zolmitriptan (311C90): are brain stem sites therapeutic target in migraine? (Q48896233)
Jump to navigation
Jump to search
scientific article published in October 1996
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Inhibition of trigeminal neurons by intravenous administration of the serotonin (5HT)1B/D receptor agonist zolmitriptan (311C90): are brain stem sites therapeutic target in migraine? |
scientific article published in October 1996 |
Statements
1 reference
Inhibition of trigeminal neurons by intravenous administration of the serotonin (5HT)1B/D receptor agonist zolmitriptan (311C90): are brain stem sites therapeutic target in migraine? (English)
1 reference
Goadsby PJ
1 reference
Hoskin KL
1 reference
1 October 1996
1 reference
1 reference
67
1 reference
2-3
1 reference
355-359
1 reference
Identifiers
1 reference
1 reference